IRONWOOD PHARMACEUTICALS INC 4

Jeffrey Silber, an SVP at Ironwood Pharmaceuticals, was granted 137,036 RSUs of Class A Common Stock as a new-hire equity award.

On July 20, 2026, Jeffrey Silber, SVP, CMO, Head-Res&Drug of Ironwood Pharmaceuticals Inc., received a new-hire restricted stock unit award covering 137,036 shares of Class A Common Stock, with no exercise price and vesting in four equal annual installments of 25% each on or around the anniversary of the grant date; following this award, his direct ownership increased to 137,036 shares.

Filing Facts

CIK

1446847

Ticker

IRWD

Form

4

Source Type

fda

Accession

0001193125-26-312410

Alert Tier

5